Zacks Investment Research
29 Jun 2026, 11:51 UTC · 1h ago
Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jun 2026, 11:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Orthofix (OFIX) shares rose 5.1% to $9.78 on high trading volume following solid first quarter 2026 performance. — Immediate positive price action and high volume suggest strong short-term investor interest in the stock.
+0.30Analysts expect Orthofix to report a quarterly loss of $0.03 per share and revenues of $209.51 million in its upcoming report. — Forward-looking estimates suggest an improvement in earnings (narrowing loss) and slight revenue growth.
+0.20Orthofix reported first quarter 2026 revenues of $196.7 million and a loss per share of 52 cents. — Provides the fundamental baseline for the company's current financial health, though the loss offsets the revenue gain.
+0.10Continue reading
6 related stories
Top 1 mover · tap to explore
The consensus EPS estimate for Orthofix has remained unchanged over the last 30 days. — Lack of positive earnings revisions often limits the sustainability of a stock's upward price momentum.
-0.10Which stocks this story touches
Shares ended the session 5.1% higher following optimism surrounding solid first quarter performance.
Shares finished the session 1.6% higher and have returned 6.9% over the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
2h ago
